D&P BIOINNOVATIONS

#medtech

We are developing an implantable, bioresorbable medical device to functionally regenerate a damaged esophagus within the body. Our device will treat those suffering from severe GERD/ advanced Barrett’s Esophagus (chronic regurgitation of stomach acid), esophageal cancer and in pediatrics where birth defects of the esophagus and poisonous ingestions are fatal addressing the $20 billion U.S. annual market. Our product improves the standard of care by avoiding surgical reconstruction from the stomach (gastric pull up) and saves over $240,000 per treatment as compared to the standard.